Jiangsu Jibeier Pharmaceutical Co Ltd
688566
Company Profile
Business description
Jiangsu Jibeier Pharmaceutical Co Ltd specializes in the research, development, production and sales of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company's products include tablets, hard capsules, eye drops, and gels, agents, creams and other dosage. Its products are used in various application fields such as Cardiovascular drugs, Blood system drugs, Immune system drugs, Ophthalmic drugs, Antipyretic and analgesic drugs, Respiratory medicine, and other.
Contact
High-tech Industrial Development Zone
Jiangsu Province
Zhenjiang212000
CHNT: +86 51188898101
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,327
Stocks News & Analysis
stocks
Our three most overvalued ASX shares
These three companies are trading at a significant premium to our fair value.
stocks
What does big US court decision mean for Google’s parent company Alphabet?
Alphabet shares popped 7% after the ruling on September 2 and have now rallied by around 50% since April.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,140.50 | 11.00 | 0.12% |
| CAC 40 | 7,656.10 | 42.82 | -0.56% |
| DAX 40 | 23,625.66 | 144.67 | -0.61% |
| Dow JONES (US) | 45,316.53 | 304.76 | -0.67% |
| FTSE 100 | 9,204.98 | 11.89 | -0.13% |
| HKSE | 25,417.98 | 359.47 | 1.43% |
| NASDAQ | 21,621.71 | 85.98 | -0.40% |
| Nikkei 225 | 43,018.75 | 438.48 | 1.03% |
| NZX 50 Index | 13,190.32 | 33.21 | -0.25% |
| S&P 500 | 6,464.58 | 37.50 | -0.58% |
| S&P/ASX 200 | 8,871.20 | 8.60 | 0.10% |
| SSE Composite Index | 3,812.51 | 46.64 | 1.24% |